Cargando…

Recent Advances in Zein-Based Nanocarriers for Precise Cancer Therapy

Cancer has emerged as a leading cause of death worldwide. However, the pursuit of precise cancer therapy and high-efficiency delivery of antitumor drugs remains an enormous obstacle. The major challenge is the lack of a smart drug delivery system with the advantages of biodegradability, biocompatibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wenquan, Yao, Fei, Tian, Shuangyan, Liu, Mohao, Liu, Guijin, Jiang, Yanbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384823/
https://www.ncbi.nlm.nih.gov/pubmed/37514006
http://dx.doi.org/10.3390/pharmaceutics15071820
_version_ 1785081251802120192
author Huang, Wenquan
Yao, Fei
Tian, Shuangyan
Liu, Mohao
Liu, Guijin
Jiang, Yanbin
author_facet Huang, Wenquan
Yao, Fei
Tian, Shuangyan
Liu, Mohao
Liu, Guijin
Jiang, Yanbin
author_sort Huang, Wenquan
collection PubMed
description Cancer has emerged as a leading cause of death worldwide. However, the pursuit of precise cancer therapy and high-efficiency delivery of antitumor drugs remains an enormous obstacle. The major challenge is the lack of a smart drug delivery system with the advantages of biodegradability, biocompatibility, stability, targeting and response release. Zein, a plant-based protein, possesses a unique self-assembly ability to encapsulate anticancer drugs directly or indirectly. Using zein as a nanotherapeutic pharmaceutic preparation can protect anticancer drugs from harsh environments, such as sunlight, stomach acid and pepsin. Moreover, the surface functionalization of zein is easily realized, which can endow it with targeting and stimulus-responsive release capacity. Hence, zein is an ideal nanocarrier for the precise delivery of anticancer drugs. Combined with our previous research experiences, we attempt to review the current state of the preparation of zein-based nanocarriers for anticancer drug delivery. The challenges, solutions and development trends of zein-based nanocarriers for precise cancer therapy are discussed. This review will provide a guideline for precise cancer therapy in the future.
format Online
Article
Text
id pubmed-10384823
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103848232023-07-30 Recent Advances in Zein-Based Nanocarriers for Precise Cancer Therapy Huang, Wenquan Yao, Fei Tian, Shuangyan Liu, Mohao Liu, Guijin Jiang, Yanbin Pharmaceutics Review Cancer has emerged as a leading cause of death worldwide. However, the pursuit of precise cancer therapy and high-efficiency delivery of antitumor drugs remains an enormous obstacle. The major challenge is the lack of a smart drug delivery system with the advantages of biodegradability, biocompatibility, stability, targeting and response release. Zein, a plant-based protein, possesses a unique self-assembly ability to encapsulate anticancer drugs directly or indirectly. Using zein as a nanotherapeutic pharmaceutic preparation can protect anticancer drugs from harsh environments, such as sunlight, stomach acid and pepsin. Moreover, the surface functionalization of zein is easily realized, which can endow it with targeting and stimulus-responsive release capacity. Hence, zein is an ideal nanocarrier for the precise delivery of anticancer drugs. Combined with our previous research experiences, we attempt to review the current state of the preparation of zein-based nanocarriers for anticancer drug delivery. The challenges, solutions and development trends of zein-based nanocarriers for precise cancer therapy are discussed. This review will provide a guideline for precise cancer therapy in the future. MDPI 2023-06-26 /pmc/articles/PMC10384823/ /pubmed/37514006 http://dx.doi.org/10.3390/pharmaceutics15071820 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Huang, Wenquan
Yao, Fei
Tian, Shuangyan
Liu, Mohao
Liu, Guijin
Jiang, Yanbin
Recent Advances in Zein-Based Nanocarriers for Precise Cancer Therapy
title Recent Advances in Zein-Based Nanocarriers for Precise Cancer Therapy
title_full Recent Advances in Zein-Based Nanocarriers for Precise Cancer Therapy
title_fullStr Recent Advances in Zein-Based Nanocarriers for Precise Cancer Therapy
title_full_unstemmed Recent Advances in Zein-Based Nanocarriers for Precise Cancer Therapy
title_short Recent Advances in Zein-Based Nanocarriers for Precise Cancer Therapy
title_sort recent advances in zein-based nanocarriers for precise cancer therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384823/
https://www.ncbi.nlm.nih.gov/pubmed/37514006
http://dx.doi.org/10.3390/pharmaceutics15071820
work_keys_str_mv AT huangwenquan recentadvancesinzeinbasednanocarriersforprecisecancertherapy
AT yaofei recentadvancesinzeinbasednanocarriersforprecisecancertherapy
AT tianshuangyan recentadvancesinzeinbasednanocarriersforprecisecancertherapy
AT liumohao recentadvancesinzeinbasednanocarriersforprecisecancertherapy
AT liuguijin recentadvancesinzeinbasednanocarriersforprecisecancertherapy
AT jiangyanbin recentadvancesinzeinbasednanocarriersforprecisecancertherapy